MAP3K7CL 抗体 (AA 151-242) (Cy7)
Quick Overview for MAP3K7CL 抗体 (AA 151-242) (Cy7) (ABIN2171263)
抗原
See all MAP3K7CL 抗体适用
宿主
克隆类型
标记
应用范围
-
-
抗原表位
- AA 151-242
-
交叉反应
- 大鼠
-
预测反应
- Human,Cow,Sheep,Pig,Horse,Rabbit
-
纯化方法
- Purified by Protein A.
-
免疫原
- KLH conjugated synthetic peptide derived from human MAP3K7CL
-
亚型
- IgG
-
-
-
-
应用备注
-
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200 -
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
浓度
- 1 μg/μL
-
缓冲液
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
-
储存液
- ProClin
-
注意事项
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
储存条件
- -20 °C
-
储存方法
- Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
-
有效期
- 12 months
-
-
- MAP3K7CL (MAP3K7 C-Terminal Like (MAP3K7CL))
-
别名
- C21orf7
-
背景
-
Synonyms: Chromosome 21 open reading frame 7, Putative gene TGF beta activated kinase like, TAK1 like, TAK1 like protein, TAK1-like protein, Tak1l, TAK1L_HUMAN, TAKL.
Background: C21orf7
-
UniProt
- P57077
抗原
-